TLIK — Arzneiwerk VIDA AG Income Statement

0.000.00%

Last trade - 00:00

TelecomsHighly SpeculativeMicro CapSucker Stock

Annual income statement for Arzneiwerk VIDA AG, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.

	R2021 December 31st	R2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	GAS	GAS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	2.36	73.4	59.3	0.207	0.069
Cost of Revenue
Gross Profit	1.86	3.14	3.33	0.207	0.069
Selling / General / Administrative Expenses
Depreciation and Amortization
Operating Interest Expense / Income
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	2.58	91	61.7	0.809	0.359
Operating Profit	-0.223	-17.7	-2.42	-0.602	-0.29
Total Net Non Operating Interest Income / Expense
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	-0.245	-18	-3.02	-0.835	-0.564
Provision for Income Taxes
Net Income After Taxes	-0.245	-16.9	-2.88	-0.836	-0.564
Net Income Before Extraordinary Items
Extraordinary Items
Net Income	-0.245	-16.6	-2.88	-0.836	-0.564
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	-0.245	-16.6	-2.88	-0.836	-0.564
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	-0.055	-1.11	-0.462	-0.134	-0.096
Dividends per Share